William Blair & Company’s Immunogen Inc IMGN Stock Holding History

William Blair & Company’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-130,723	Closed	-$3.88M	–	1867
2023 Q4	$3.88M	Sell	130,723 -123,597	-49%	-$3.66M	0.01%	520
2023 Q3	$4.04M	Sell	254,320 -1,685	-0.7%	-$26.7K	0.02%	485
2023 Q2	$4.83M	Sell	256,005 -323,590	-56%	-$6.11M	0.02%	460
2023 Q1	$2.23M	Buy	579,595 +235,000	+68%	+$902K	0.01%	632
2022 Q4	$1.71M	Buy	344,595 +77,750	+29%	+$386K	0.01%	674
2022 Q3	$1.28M	Buy	266,845 +400	+0.2%	+$1.91K	0.01%	740
2022 Q2	$1.2M	Sell	266,445 -271,965	-51%	-$1.22M	0.01%	783
2022 Q1	$2.56M	Buy	538,410 +2,925	+0.5%	+$13.9K	0.01%	631
2021 Q4	$3.97M	Buy	535,485 +19,885	+4%	+$148K	0.01%	535
2021 Q3	$2.92M	Buy	515,600 +691	+0.1%	+$3.92K	0.01%	600
2021 Q2	$3.39M	Sell	514,909 -891	-0.2%	-$5.87K	0.01%	556
2021 Q1	$4.18M	Buy	515,800 +305,400	+145%	+$2.47M	0.02%	493
2020 Q4	$1.36M	Buy	210,400 +41,030	+24%	+$265K	0.01%	762
2020 Q3	$610K	Buy	169,370 +1,100	+0.7%	+$3.96K	﹤0.01%	913
2020 Q2	$774K	Buy	168,270 +2,412	+1%	+$11.1K	﹤0.01%	802
2020 Q1	$566K	Sell	165,858 -11,798	-7%	-$40.3K	﹤0.01%	833
2019 Q4	$907K	Buy	177,656 +3,957	+2%	+$20.2K	﹤0.01%	807
2019 Q3	$420K	Buy	173,699 +7,100	+4%	+$17.2K	﹤0.01%	1003
2019 Q2	$362K	Buy	166,599 +91,692	+122%	+$199K	﹤0.01%	1092
2019 Q1	$419K	Buy	74,907 +9,434	+14%	+$52.8K	﹤0.01%	1019
2018 Q4	$366K	Buy	+65,473	New	+$366K	﹤0.01%	1015
2015 Q1	–	Sell	-17,571	Closed	-$106K	–	2192
2014 Q4	$106K	Sell	17,571 -6,013	-25%	-$36.3K	﹤0.01%	2010
2014 Q3	$250K	Buy	23,584 +2,000	+9%	+$21.2K	﹤0.01%	1902
2014 Q2	$255K	Sell	21,584 -562	-3%	-$6.64K	﹤0.01%	1862
2014 Q1	$330K	Sell	22,146 -2,000	-8%	-$29.8K	﹤0.01%	1733
2013 Q4	$354K	Sell	24,146 -1,409	-6%	-$20.7K	﹤0.01%	1691
2013 Q3	$434K	Buy	25,555 +555	+2%	+$9.43K	﹤0.01%	1597
2013 Q2	$414K	Buy	+25,000	New	+$414K	﹤0.01%	1557